Introduction {#s1}
============

Chronic liver disease is a multi-system disorder which leads to decreased quality of life and life expectancy. Patients with cirrhosis are also at increased risk of morbidity and mortality after surgery.[@b1]--[@b3] Postoperative mortality after non-transplant surgery is 11--25% for cirrhotic patients, compared to 1.1% for patients without cirrhosis of the liver.[@b4] Patient selection and prognostication is therefore crucial. Several risk scoring systems, including the American Society of Anesthesiologists (ASA) physical status classification, Child-Turcotte-Pugh (CTP) classification and model for end-stage liver disease (MELD) scoring, are used to prognosticate outcomes and risk associated with surgery. However, unlike any of those listed above, the Mayo postoperative mortality risk prediction model was designed specifically to predict mortality after non-transplant surgery for patients with cirrhosis of the liver.

We performed a retrospective analysis of the patients with cirrhosis of the liver who had been operated upon with surgeries other than liver transplant surgery at our hospital. Their expected mortality was calculated using the Mayo risk score, on the basis of each patient's preoperative investigative findings, and assessed for correlation with expected mortality in comparison to the observed mortality over a period of 1 year after surgery. We also looked for correlation of the observed mortality with the MELD and model for end-stage liver disease-sodium (MELD-Na) scores and with the CTP score.

Methods {#s2}
=======

This study was approved by the Institutional Ethics Committee (Vide letter IEC/2017/49/MA11, dated 6/4/2017). The hospital's electronic information system and scanned copies of patient physical records were accessed. We identified 240 patients with cirrhosis of the liver who were operated upon for non-transplant surgery under general anesthesia between the dates of October 2009 and June 2017. Among all the patients identified by these criteria, 90 could not be traced for telephonic follow-up and data was incomplete for another 17. Complete data was available for 133 cirrhotic patients who had undergone various gastro-intestinal, hepato-pancreatico-biliary and urological surgeries, excluding liver transplant surgery. All included patients had cirrhosis documented by (i) histological findings, (ii) clinical findings, and/ or (iii) radiological imaging findings consistent with cirrhosis of the liver.

Elective as well as emergency surgeries were included in the study. Each patient was categorized by an anesthesiologist before the surgery into one of the five ASA classes.[@b5] The CTP score, MELD and MELD-Na scores were calculated.[@b6]--[@b9] Lengths of hospital and Intensive Care Unit stays, type of surgery, date of surgery, and date of death of the patient (whenever applicable) were obtained. Patients discharged to home were contacted by telephone to ascertain their outcome. Postoperative mortality risk was calculated on the website provided by the Mayo clinic (<http://www.mayoclinic.org/meld/mayomodel9.html>).[@b10] Follow-up was conducted for up to 1 year or until the time of death within the 1 year following the surgery. Patients diagnosed with cirrhosis after the surgery and patients with acute liver failure and/or acute-on-chronic liver disease were not included. Patients who underwent liver transplant surgery before or during the study period were also excluded from the study.

Statistical analysis {#s2-1}
--------------------

Categorical variables were presented as proportions, while continuous variables were presented either as mean with standard deviation or median with range. Comparison of two continuous variables was done by independent *t-*test or Mann-Whitney test for parametric or nonparametric data respectively, and categorical variables by Fisher's exact test or Pearson's chi-square test. Pearson's or Spearman's correlation coefficient was used for measuring any association between variables. Univariate regression analysis was used for calculating risk for disease severity score. All statistical analyses were two-tailed and used a significance level (*p*) of \<0.05, and were carried out by the SPSS statistical software for Windows (version 22; IBM Corp., Armonk, NY, USA).

Results {#s3}
=======

A total of 133 patients diagnosed with cirrhosis of the liver were included in this study. Males formed the majority of the study population, accounting for 84% (*n* = 112), and the mean age was 51 years. The average MELD score was 17, MELD-Na score was 20, CTP score was 9. Out of the 133 patients, 12, 83 and 38 were grouped into CTP classes A, B and C respectively. One hundred and fourteen patients (86%) were classified as ASA class III, and the rest (14%) as ASA class IV. Thirty-seven patients (28%) were operated upon for emergency surgical intervention ([Table 1](#t01){ref-type="table"}).

###### Demographic profile of the study population

  Characteristic                                                     Number of patients
  ------------------------------------------------------------------ --------------------------
  Total number of patients, *n*                                      133
  Mean age in years                                                  51 ± 11.6
  Sex, M/F                                                           112/21
  MELD score as mean ± SD (Survivor vs. Non-Survivor at 1 year)      18 ± 8.5 (15.4 vs. 23.5)
  MELD-Na score as mean ± SD (Survivor vs. Non-Survivor at 1 year)   20 ± 8.5 (18.4 vs. 23.9)
  CTP class, *n* (%) for A                                           12 (9%)
  CTP class, *n* (%) for B                                           83 (62%)
  CTP class, *n* (%) for C                                           38 (29%)
  CTP score as mean ± SD (Survivor vs. Non-Survivor)                 8.6 ± 2.6 (8.1 vs. 10.0)
  ASA status, *n* (%) for III                                        114 (86%)
  ASA status, *n* (%) for IV                                         19 (14%)
  Emergency surgery, *n* (%)                                         37 (28%)
  Etiology of cirrhosis, *n* (%)                                     
   Alcoholic                                                         46 (35%)
   Viral                                                             40 (30%)
   Non-alcoholic steatohepatitis                                     21 (15%)
   Cryptogenic                                                       15 (11%)
   Others[^\*^](#table1fn1){ref-type="fn"}                           11 (9%)
  Observed mortality at 30 days, *n* (%)                             16 (12%)
  Observed mortality at 90 days, *n* (%)                             27 (20.3%)
  Observed mortality at 1 year, *n* (%)                              35 (20.3%)

Others: Non-cirrhotic portal fibrosis -- 3, autoimmune hepatitis -- 2, hepatic venous outflow tract obstruction -- 2, primary biliary cholangitis -- 1, primary sclerosing cholangitis -- 1, extrahepatic portal venous obstruction -- 1, chronic cholestatic liver disease -- 1.

No patient was hypertensive or had diabetes mellitus at the time of the diagnosis of cirrhosis of the liver. Unconfirmed history of hypertension was present in 17 patients, but at the time of diagnosis of cirrhosis of the liver no patient was found to be hypertensive. Renal dysfunction or a history of renal dysfunction secondary to cirrhosis of the liver was present in 108 of 133 patients. Alcoholic liver disease (35%) was closely followed by viral etiology (30%) as the cause for the cirrhosis of the liver. The overall 30-day, 90-day and 1-year observed mortality rates were 12%, 20.3% and 26.3% respectively.

There was a good correlation between the observed mortality and the predicted mortality, as calculated by using the Mayo risk calculator, among our study population, with the area under the receiver operating characteristic curve (commonly known as AUROC) for 30-day, 90-day and 1-year mortality of 0.836, 0.826 and 0.744 respectively, sensitivity of 73.3%, 73.1% and 67.6% respectively, and specificity of 75%, 75% and 65.6% respectively ([Table 2](#t02){ref-type="table"}) ([Fig. 1](#f01){ref-type="fig"}).

###### Area under the receiver operating characteristic curves for the observed mortality and different scores

                    Area under the curve   Cutoff value   Sensitivity   Specificity   *p*
  ----------------- ---------------------- -------------- ------------- ------------- ---------
  Mayo 30 days      0.84                   29.5           73.3          73.0          \<0.001
  Mayo 90 days      0.83                   41.5           73.0          75.0          \<0.001
  Mayo 1 year       0.75                   41.0           67.6          69.7          \<0.001
  MELD 30 days      0.83                   19.5           75.0          72.6          \<0.001
  MELD 90 days      0.83                   18.5           74.1          73.6          \<0.001
  MELD 1 year       0.76                   16.5           68.6          63.0          \<0.001
  MELD-Na 30 days   0.77                   24.5           75.0          74.5          0.001
  MELD-Na 90 days   0.74                   21.5           66.7          67.0          0.001
  MELD-Na 1 year    0.67                   20.5           60.0          60.2          0.003

![Receiver operating characteristic curves for MAYO score predicted mortality.](JCTH-7-009-g001){#f01}

We plotted receiver operating characteristic curve and found a cutoff of 19.5 for MELD score and 24.5 for MELD-Na score, above which the 30-day mortality increased for every point increase in score ([Table 2](#t02){ref-type="table"}) ([Figs. 2](#f02){ref-type="fig"} and [3](#f03){ref-type="fig"}). We also found that for every point increase in MELD score above the cutoff value, the mortality at day 30, day 90 and 1 year increased by 16% (odds ratio (OR): 1.16, 95% confidence interval (CI): 1.08--1.25, *p* \< 0.001), 16% (OR: 1.16, 95% CI: 1.09--1.24, *p* \< 0.001) and 12% (OR: 1.12, 95% CI: 1.07--1.18, *p* \< 0.001) respectively. Similarly, for every point increase in MELD-Na score above the cutoff value, the mortality at day 30, day 90 and at 1 year increased by 13% (OR: 1.13, 95% CI: 1.06--1.23, *p* \< 0.001), 12% (OR: 1.12, 95% CI: 1.06--1.19, *p* \< 0.001) and 8% (OR: 1.08, 95% CI: 1.03--1.14, *p* \< 0.001) respectively. Whereas, for every unit change in CTP score, the OR of mortality at day 30 was 1.86 (95% CI: 1.38--2.50, *p* \< 0.001), at day 90 was 1.56 (95% CI: 1.28--1.90, *p* \< 0.001) and at 1 year was 1.35 (95% CI: 1.15--1.59, *p* \< 0.001) ([Table 3](#t03){ref-type="table"}).

![Receiver operating characteristic curves for MELD score predicted mortality.](JCTH-7-009-g002){#f02}

![Receiver operating characteristic curves for MELD-Na score predicted mortality.](JCTH-7-009-g003){#f03}

###### Univariate analysis for MELD and MELD-Na scores and CTP class

  Variable            Odds ratio
  ------------------- ----------------------------------------
  **MELD score**      
   30-day mortality   1.16, 95% CI: 1.08--1.25, *p* \< 0.001
   90-day mortality   1.16, 95% CI: 1.09--1.24, *p* \< 0.001
   1-year mortality   1.12, 95% CI: 1.07--1.18, *p* \< 0.001
  **MELD-Na score**   
   30-day mortality   1.13, 95% CI: 1.06--1.23, *p* \< 0.001
   90-day mortality   1.12, 95% CI: 1.06--1.19, *p* \< 0.001
   1-year mortality   1.08,95% CI: 1.03--1.14, *p* \< 0.001
  **CTP class**       
   30-day mortality   1.86, 95% CI: 1.38--2.50, *p* \< 0.001
   90-day mortality   1.56, 95% CI: 1.28--1.90, *p* \< 0.001
   1-year mortality   1.35, 95% CI: 1.15--1.59, *p* \< 0.001

For CTP class A, B and C, mortality at day 30 was 0/16, 4/16 and 12/16, (*p* \< 0.001) respectively, at day 90 was 1/27, 10/27 and 16/27 respectively (*p* \< 0.001), and at 1 year was 3/35, 14/35 and 18/35 respectively (*p* = 0.002) ([Table 4](#t04){ref-type="table"}). Overall mortality in the observed period of 1 year for ASA class III and IV was 20.2 and 73.7% respectively. Emergency surgeries accounted for the significant number of mortalities in both ASA class III and IV ([Table 5](#t05){ref-type="table"}). Gastrointestinal and urology surgeries accounted for the majority of the surgical interventions ([Table 6](#t06){ref-type="table"}).

###### Mortality and the CTP class

  CTP class     30-day mortality   90-day mortality   1-year mortality
  ------------- ------------------ ------------------ ------------------
  A, *n* = 12   0                  1 (3.7%)           3 (8.6%)
  B, *n* = 83   4 (25%)            10 (37%)           14 (40%)
  C, *n* = 38   12 (75%)           16 (59.3%)         18 (51.4%)
  Total         16                 27                 35

###### Observed mortality and ASA status

  ASA class        Elective cases   Emergency cases   Mortality in emergency cases   Overall mortality
  ---------------- ---------------- ----------------- ------------------------------ -------------------
  III, *n* = 114   92               22                4 (19.3%)                      23 (20.2%)
  IV, *n* = 19     4                15                12 (63.2%)                     14 (73.7%)

###### Type of non-transplant surgeries that patients with cirrhosis of the liver underwent

  Type of surgery    Number of surgeries
  ------------------ ---------------------
  Gastrointestinal   70
  Urological         37
  Hepatic            6
  Superficial        
   I & D             10
   Trachestomy       5
  ENT                3
  Neuro              2

Discussion {#s4}
==========

Surgical intervention for various reasons is made in approximately 10% of patients with chronic liver disease within 2 years before their death.[@b11] Surgery in this group of patients is associated with high mortality, of 11--25%.[@b4] Type of surgery, CTP score and MELD score have each been independently associated with postoperative morbidity and mortality in such patients with cirrhosis of the liver.[@b12]

The Mayo risk calculator is a tool used for prognosticating risk of mortality among patients with cirrhosis of the liver presenting for any surgery, excluding liver transplant. In this study, we analyzed 133 patients with cirrhosis of the liver who had been operated on for non-transplant surgery and found that the Mayo risk calculator was able to predict the observed mortality at day 30, day 90 and at 1 year, with AUROCs of 84%, 83% and 72% respectively ([Table 2](#t02){ref-type="table"}).

In a systematic review of 100 cirrhotic patients, predominantly of ethanol origin and who were undergoing abdominal surgery, the perioperative mortality rates of 10%, 31% and 76% were reported for the patients classified as Child's class A, B and C respectively.[@b13] Out of 52 parameters that were assessed in a multivariate analysis, Child's classification was the best predictor of surgical mortality and morbidity. In this study, we found that in addition to CTP score, MELD and MELD-Na scores are also independent predictors of mortality at day 30, day 90 and at 1 year ([Table 3](#t03){ref-type="table"}).

Teh *et al.*[@b10] studied 772 patients with cirrhosis of the liver and found MELD score, age and ASA class to be statistically significant predictors of mortality. ASA class was the strongest predictor of the 7-day mortality, whereas MELD score was the best predictor of 30-day, 90-day and long-term postoperative mortality, for all types of surgery. Teh *et al.*[@b10] also concluded that the relative risk of 30- and 90-day mortality increased by 14% with each 1-point increase in the MELD score. Another study by Northup *et al.*[@b15] concluded that 1% increase in mortality occurs for every point increase in MELD score less than 20 and that there is an additional 2% increase in mortality for every MELD point increase greater than 20. Our study also found that for every point increase in MELD score, the mortality at 30 days, 90 days and 1 year increased by 16%, 16% and 12% respectively and that for every 1-point increase in MELD-Na score the mortality increased by 13%, 12% and 8% respectively ([Table 3](#t03){ref-type="table"}).

We also plotted the receiver operated characteristic curve and calculated the best cutoff values for predicted mortality using Mayo risk calculator. The cutoff values thus derived imply that predicted mortality, more than these cutoff values, was associated with significant risk of actual mortality in our study population. The area under the curve for mortality at 30 days was 0.84, with significant cutoff at 29.5 having sensitivity and specificity of 73.3% and 75% respectively. For mortality at 90 days, the area under the curve was 0.83, with cutoff at 41.5 having sensitivity and specificity of 73% and 75% respectively. Similarly, for mortality at 1-year post-surgery, the area under the curve was 0.74 with cutoff at 38 having sensitivity and specificity of 67.6% and 65.6% respectively.

Kim *et al.*[@b14] carried out a retrospective analysis to validate the Mayo postoperative risk prediction model in Korean cirrhotic patients. In their analysis, the data of 160 cirrhotic patients undergoing surgery under general anesthesia were reviewed and CTP score, MELD score, ASA class and age were found to be significant predictors of postoperative mortality in cirrhotic patients. Moreover, the Mayo model for risk prediction showed good correlation in cirrhosis of the liver among Korean patients but the model tended to overestimate mortality, especially at 1-year post-surgery. In our study also, the Mayo risk model was seen to overestimate the mortality. The mean mortality calculated by the Mayo model for our study population at postoperative day 30, day 90 and 1 year was 26%, 34.5% and 41.8% respectively, which was significantly higher than the observed mortality of 12%, 20% and 26% respectively.

In the study by Kim *et al.*[@b14] the overall 30-day, 90-day and 1-year mortality rates were 7.5%, 9.4% and 10.6% respectively, as compared to 12%, 20.3% and 26.3% in our study. The relatively higher mortality percentage seen in our study population is probably because of the higher mean MELD score of 18 versus that of 6 in the Korean group, implying sicker patients among our study population. The implication of sicker patients in our study population is also reflected in the CTP class distribution; where 78% in the Korean study were of CTP A, only 9% of our patients were CTP A.

In a retrospective study of 140 cirrhotic patients undergoing non-transplant surgeries, the mean MELD score of survivors was compared against the mean MELD score of non-survivors (16.2 vs. 24.8).[@b15] A similar difference was seen in our study, wherein the mean MELD score of survivors at 1 year after surgery was 15.4, while it was 23.5 for our non-survivors. In our study, the patients who did not survive had a mean MELD-Na score of 23.9 and a mean CTP of 10 ([Table 1](#t01){ref-type="table"})

The ASA classification incorporates measures of cardiopulmonary function that are critical for determination of survival in patients with cirrhosis of the liver.[@b16] ASA score is an independent risk factor for early as well as for late (i.e. after 1 year) mortality.[@b9]--[@b13] In this study, we observed a 74% mortality (*n* = 14) and 21% mortality (*n* = 24) among the patients of ASA class IV and III respectively. Thirty-seven patients were operated on for emergency situations, of which 16 died (43%) ([Table 5](#t05){ref-type="table"}). Such high mortality for emergency surgical procedures in patients with cirrhosis of liver has also been reported by Rice *et al.*[@b1]

Limitations {#s4-1}
-----------

This study has certain limitations, including the use of a retrospective analysis approach and a small sample size. The number of patients who were denied surgery by the surgeon, anesthesiologist or the patients themselves based upon the expected high risk nature is not known and could have led to a selection bias towards surgical interventions in patients with less advanced or well-compensated liver disease.

Conclusions {#s5}
===========

High morbidity associated with surgical intervention in patients with cirrhosis of the liver warrants development of scientific models to prognosticate the outcome. The Mayo clinic risk calculator is good at predicting mortality but its efficacy in our patient population, we found, decreases with increase in duration after surgery. There is thus need to develop risk prognostication models suited for local populations. Until such time as these models are available, the Mayo risk calculation model may continue to be used with mortality risk cutoffs for the local population as derived in this study. MELD and MELD-Na scores and CTP classes may also be used to prognosticate mortality risk in such patients with cirrhosis of the liver.

AUROC
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:   model for end-stage liver disease
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